{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:54:37Z","timestamp":1775199277571,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068633"],"award-info":[{"award-number":["UM1AI068633"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068615"],"award-info":[{"award-number":["UM1AI068615"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI106707"],"award-info":[{"award-number":["UM1AI106707"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["T32MH19139"],"award-info":[{"award-number":["T32MH19139"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["P30MH43520"],"award-info":[{"award-number":["P30MH43520"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s10461-020-03026-6","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T17:03:19Z","timestamp":1599930199000},"page":"721-731","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sharing Objective Measures of Adherence to a Vaginal Microbicide Promotes Candor About Actual Use and Bolsters Motivation to Prevent HIV"],"prefix":"10.1007","volume":"25","clinical-trial-number":[{"clinical-trial-number":"nct02858037","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Bryan Andrew","family":"Kutner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Giguere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cody","family":"Lentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare","family":"Kajura-Manyindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis","family":"Dolezal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samkelisiwe","family":"Butheliezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Gwande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Nampiira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thakasile","family":"Ndlovu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla","family":"Mvinjelwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wezi","family":"Mwenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6301-7075","authenticated-orcid":false,"given":"Iv\u00e1n C.","family":"Bal\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,12]]},"reference":[{"key":"3026_CR1","first-page":"324","volume":"66","author":"AL Corneli","year":"2014","unstructured":"Corneli AL, Deese J, Wang M, Taylor D, Ahmed K, Agot K, et al. FEM-PrEP: Adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis. JAIDS. 2014;66:324\u201331.","journal-title":"JAIDS"},{"key":"3026_CR2","first-page":"528","volume":"67","author":"A Liu","year":"2014","unstructured":"Liu A, Glidden DV, Anderson PL, Amico RK, McMahan V, Mehrotra M, et al. Patterns and correlates of PrEP drug detection among MSM and transgender women in the global iPrEx study. JAIDS. 2014;67:528\u201337.","journal-title":"JAIDS"},{"key":"3026_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. New Engl J Medicine. 2015;372:509\u201318.","journal-title":"New Engl J Medicine"},{"key":"3026_CR4","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. New Engl J Medicine. 2016;375:2121\u201332.","journal-title":"New Engl J Medicine"},{"key":"3026_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11904-012-0141-9","volume":"10","author":"A van der Straten","year":"2012","unstructured":"van der Straten A, Montgomery ET, Hartmann M, Minnis A. Methodological lessons from clinical trials and the future of microbicide research. Curr HIV-AIDS Rep. 2012;10:89\u2013102.","journal-title":"Curr HIV-AIDS Rep"},{"key":"3026_CR6","first-page":"530","volume":"66","author":"RK Amico","year":"2014","unstructured":"Amico RK, Marcus JL, McMahan V, Liu A, Koester KA, Goicochea P, et al. Study product adherence measurement in the iPrEx placebo-controlled trial: Concordance with drug detection. JAIDS. 2014;66:530\u20137.","journal-title":"JAIDS"},{"key":"3026_CR7","doi-asserted-by":"publisher","first-page":"20642","DOI":"10.7448\/IAS.19.1.20642","volume":"19","author":"A van der Straten","year":"2016","unstructured":"van der Straten A, Brown ER, Marrazzo JM, Chirenje MZ, Liu K, Gomez K, et al. Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study. JIAS. 2016;19:20642.","journal-title":"JIAS"},{"key":"3026_CR8","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1007\/s10461-017-1958-4","volume":"22","author":"Z Baker","year":"2017","unstructured":"Baker Z, Javanbakht M, Mierzwa S, Pavel C, Lally M, Zimet G, et al. Predictors of over-reporting HIV pre-exposure prophylaxis (PrEP) adherence among young men who have sex with men (YMSM) in self-reported versus biomarker data. AIDS Behav. 2017;22:1174\u201383.","journal-title":"AIDS Behav"},{"key":"3026_CR9","doi-asserted-by":"publisher","first-page":"19158","DOI":"10.7448\/IAS.17.3.19158","volume":"17","author":"KM MacQueen","year":"2014","unstructured":"MacQueen KM, Tolley EE, Owen DH, Amico RK, Morrow KM, Moench T, et al. An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal rings. JIAS. 2014;17:19158.","journal-title":"JIAS"},{"key":"3026_CR10","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1097\/QAD.0000000000000801","volume":"29","author":"A van der Straten","year":"2015","unstructured":"van der Straten A, Montgomery ET, Musara P, Etima J, Naidoo S, Laborde N, et al. Disclosure of pharmacokinetic drug results to understand nonadherence. AIDS. 2015;29:2161\u201371.","journal-title":"AIDS"},{"key":"3026_CR11","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1080\/09540121.2015.1039958","volume":"27","author":"KA Koester","year":"2015","unstructured":"Koester KA, Liu A, Eden C, Amico RK, McMahan V, Goicochea P, et al. Acceptability of drug detection monitoring among participants in an open-label pre-exposure prophylaxis study. AIDS Care. 2015;27:1199\u2013204.","journal-title":"AIDS Care"},{"key":"3026_CR12","doi-asserted-by":"crossref","unstructured":"Browne EN, Montgomery ET, Mansfield C, Boeri M, Mange B, Beksinska M, et al. Efficacy is Not Everything: Eliciting Women\u2019s Preferences for a Vaginal HIV prevention product using a discrete-choice experiment. AIDS Behav. 2019;1\u20139.","DOI":"10.1007\/s10461-019-02715-1"},{"key":"3026_CR13","first-page":"578","volume":"68","author":"AL Corneli","year":"2015","unstructured":"Corneli AL, McKenna K, Perry B, Ahmed K, Agot K, Malamatsho F, et al. The science of being a study participant: FEM-PrEP participants\u2019 explanations for overreporting adherence to the study pills and for the whereabouts of unused pills. JAIDS. 2015;68:578\u201384.","journal-title":"JAIDS"},{"key":"3026_CR14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s10461-017-1890-7","volume":"22","author":"R Giguere","year":"2018","unstructured":"Giguere R, Rael C, Sheinfil A, Bal\u00e1n IC, Brown W, Ho T, et al. Factors supporting and hindering adherence to rectal microbicide gel use with receptive anal intercourse in a phase 2 trial. AIDS Behav. 2018;22:388\u2013401.","journal-title":"AIDS Behav"},{"key":"3026_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10461-016-1609-1","volume":"21","author":"ET Montgomery","year":"2017","unstructured":"Montgomery ET, Mensch B, Musara P, Hartmann M, Woeber K, Etima J, et al. Misreporting of product adherence in the MTN-003\/VOICE trial for HIV prevention in Africa: Participants\u2019 explanations for dishonesty. AIDS Behav. 2017;21:481\u201391.","journal-title":"AIDS Behav"},{"key":"3026_CR16","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10461-017-1685-x","volume":"22","author":"P Musara","year":"2018","unstructured":"Musara P, Montgomery ET, Mgodi NM, Woeber K, Akello CA, Hartmann M, et al. How presentation of drug detection results changed reports of product adherence in South Africa. Uganda and Zimbabwe AIDS Behav. 2018;22:877\u201386.","journal-title":"Uganda and Zimbabwe AIDS Behav"},{"key":"3026_CR17","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s10461-017-1955-7","volume":"22","author":"IC Bal\u00e1n","year":"2018","unstructured":"Bal\u00e1n IC, Giguere R, Brown W, Alex C-D, Horn S, Hendrix CW, et al. Brief participant-centered convergence interviews integrate self-reports, product returns, and pharmacokinetic results to improve adherence measurement in MTN-017. AIDS Behav. 2018;22:986\u201395.","journal-title":"AIDS Behav"},{"key":"3026_CR18","doi-asserted-by":"crossref","unstructured":"Levy A, herer A, Zikmund-Fisher BJ, Larkin K, Barnes GD, Fagerlin A. Prevalence of and factors associated with patient nondisclosure of medically relevant information to clinicians. JAMA Netw Open. 2018;1:e185293.","DOI":"10.1001\/jamanetworkopen.2018.5293"},{"key":"3026_CR19","first-page":"73","volume":"23","author":"KM Carroll","year":"2002","unstructured":"Carroll KM, Farentinos C, Ball SA, Crits-Christoph P, Libby B, Morgenstern J, et al. MET meets the real world: Design issues and clinical strategies in the Clinical Trials Network. JSAT. 2002;23:73\u201380.","journal-title":"JSAT"},{"key":"3026_CR20","first-page":"455","volume":"61","author":"WR Miller","year":"1993","unstructured":"Miller WR, Benefield GR, Tonigan SJ. Enhancing motivation for change in problem drinking: A controlled comparison of two therapist styles. JCCP. 1993;61:455\u201361.","journal-title":"JCCP"},{"key":"3026_CR21","unstructured":"Miller WR. Motivational Enhancement Therapy Manual. DIANE Publishing. 1995;123."},{"key":"3026_CR22","unstructured":"Miller WR. Enhancing Motivation for Change in Substance Abuse Treatment. DIANE Publishing. 1999;243."},{"key":"3026_CR23","first-page":"159","volume":"28","author":"RK Hester","year":"2005","unstructured":"Hester RK, Squires DD, Delaney HD. The Drinker\u2019s Check-up: 12-month outcomes of a controlled clinical trial of a stand-alone software program for problem drinkers. JSAT. 2005;28:159\u201369.","journal-title":"JSAT"},{"key":"3026_CR24","first-page":"1","volume":"11","author":"RK Amico","year":"2018","unstructured":"Amico RK, Miller J, Balthazar C, Serrano P, Brothers J, Zollweg S, et al. Integrated Next Step Counseling (iNSC) for sexual health and PrEP Use among young men who have sex with men: Implementation and observations from ATN110\/113. AIDS Behav. 2018;11:1\u201312.","journal-title":"AIDS Behav"},{"key":"3026_CR25","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s10461-016-1360-7","volume":"20","author":"RK Amico","year":"2016","unstructured":"Amico RK, Mehrotra M, Avelino-Silva VI, McMahan V, Veloso VG, Anderson P, et al. Self-reported recent PrEP dosing and drug detection in an open label PrEP study. AIDS Behav. 2016;20:1535\u201340.","journal-title":"AIDS Behav"},{"key":"3026_CR26","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s10461-012-0182-5","volume":"16","author":"RK Amico","year":"2012","unstructured":"Amico RK, McMahan V, Goicochea P, Vargas L, Marcus JL, Grant RM, et al. Supporting study product use and accuracy in self-report in the iPrEx study: next step counseling and neutral assessment. AIDS Behav. 2012;16:1243\u201359.","journal-title":"AIDS Behav"},{"key":"3026_CR27","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1037\/a0036910","volume":"51","author":"TB Moyers","year":"2014","unstructured":"Moyers TB. The relationship in motivational interviewing. Psychotherapy. 2014;51:358\u201363.","journal-title":"Psychotherapy"},{"key":"3026_CR28","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New Engl J Medicine. 2010;363:2587\u201399.","journal-title":"New Engl J Medicine"},{"key":"3026_CR29","unstructured":"Bal\u00e1n IC, Giguere R, Lentz C, Kutner BA, Kajura-Manyindo C, Byogero R, Asiimwe, FB, Makala Y, Jamaya J, Khanyile N, Chetty D, Soto-Torres L, Mayo A, Mgodi NM, Palanee-Phillips T & Baeten J. Client-centered adherence counseling with adherence measurement feedback to support use of the dapivirine ring in MTN-025 (The HOPE Study). (Under review)"},{"key":"3026_CR30","unstructured":"IBM SPSS Statistics for Macintosh. 2017."},{"key":"3026_CR31","unstructured":"NVivo qualitative data analysis software. 2019"},{"key":"3026_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jpba.2016.03.023","volume":"125","author":"P Spence","year":"2016","unstructured":"Spence P, Nel A, van Niekerk N, Derrick T, Wilder S, Devlin B. Post-use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence. J Pharmaceut Biomed. 2016;125:94\u2013100.","journal-title":"J Pharmaceut Biomed"},{"issue":"Suppl 2","key":"3026_CR33","first-page":"S67","volume":"10","author":"J Raboud","year":"1995","unstructured":"Raboud J, Haley L, Montaner J, Murphy C, Januszewska M, Schechter M. Quantification of the variation due to laboratory and physiologic sources in CD4 lymphocyte counts of clinically stable HIV-infected individuals. JAIDS. 1995;10(Suppl 2):S67\u201373.","journal-title":"JAIDS"},{"key":"3026_CR34","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1177\/0956462418771768","volume":"29","author":"W Venter","year":"2018","unstructured":"Venter W, Chersich MF, Majam M, Akpomiemie G, Arulappan N, Moorhouse M, et al. CD4 cell count variability with repeat testing in South Africa: Should reporting include both absolute counts and ranges of plausible values? Int J STD AIDS. 2018;29:1048\u201356.","journal-title":"Int J STD AIDS"},{"key":"3026_CR35","unstructured":"Giguere R, Lentz C, Kajura-Manyindo C, Kutner BA, Dolezal C, Buthelezi M, Lukas I, Nampiira S, Rushwaya C, Sitima E, Katz A, van der Straten A & Bal\u00e1n IC. Building client-centered counseling skills for an HIV-prevention study in Africa. (Under review)"},{"key":"3026_CR36","first-page":"200","volume-title":"Brief Alcohol Screening and Intervention for College Students (BASICS)","author":"L Dimeff","year":"1999","unstructured":"Dimeff L, Baer J, Kivlahan D, Marlatt G. Brief Alcohol Screening and Intervention for College Students (BASICS). New York: Guilford Press; 1999. p. 200."},{"key":"3026_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.amepre.2008.10.016","volume":"36","author":"H Riper","year":"2009","unstructured":"Riper H, van Straten A, Keuken M, Smit F, Schippers G, Cuijpers P. Curbing problem drinking with personalized-feedback interventions: a meta-analysis. Am J Prev Med. 2009;36:247\u201355.","journal-title":"Am J Prev Med"},{"key":"3026_CR38","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.pec.2016.10.029","volume":"100","author":"PK Dillard","year":"2017","unstructured":"Dillard PK, Zuniga J, Holstad MM. An integrative review of the efficacy of motivational interviewing in HIV management. Patient Educ Couns. 2017;100:636\u201346.","journal-title":"Patient Educ Couns"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-020-03026-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-020-03026-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-020-03026-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T23:31:05Z","timestamp":1631403065000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-020-03026-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,12]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["3026"],"URL":"https:\/\/doi.org\/10.1007\/s10461-020-03026-6","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,12]]},"assertion":[{"value":"1 September 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"I confirm all patient\/personal identifiers have been removed or disguised so the patient\/person(s) described are not identifiable and cannot be identified through the details of the story.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}